Genesis Healthcare, Inc. GENNQ
—
0.00
0.00
NaN
as of 24 Sep
- Market cap
- —
- P/E
- 0.0×
Follow GENNQ
| Older periods | Dec '20 | Mar '21 | Jun '21 | Sep '21 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.22 |
P/S ratio |
0.01 | 0.01 | 0.01 | 0.01 | |
P/FCF ratio |
0.17 | 0.12 | 0.00 | 0.14 | |
P/Operating CF |
1.55 | (0.65) | 1.67 | (0.48) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.34 | 0.37 | 0.39 | 0.39 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 79.52 | |
EV/Operating CF |
4.21 | 5.42 | (26.96) | (31.82) | |
EV/FCF |
4.25 | 5.12 | (42.35) | 7.53 | |
Quick Ratio |
0.19 | 0.18 | 0.20 | 0.21 | |
Current Ratio |
0.23 | 0.22 | 0.25 | 0.26 | |
Net Debt/EBITDA |
(17.27) | (27.33) | 26.45 | 14.72 | |
Debt/Assets |
38.79% | 41.57% | 49.75% | 49.60% | |
Debt/Equity |
(1.36) | (1.28) | (1.41) | (1.45) | |
Asset Turnover |
0.90 | 0.90 | 0.95 | 0.94 | |
Operating CF/Net income |
(4.51) | 1.51 | 0.32 | (0.88) | |
Capex/Depreciation |
10.40 | (0.26) | (0.21) | (0.38) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
71.80% | 70.95% | 65.29% | 67.61% | |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.05 | 0.05 | |
Share Based Compensation of Revenue |
0.13% | 0.21% | 0.13% | 0.05% | |
Graham Net Nets |
(81.12) | (130.48) | (92.91) | (138.53) | |
Graham Number |
11.90 | 17.99 | 7.84 | 0.00 | |
Earnings Yield |
(126.10%) | (483.36%) | (91.22%) | 459.80% | |
Free Cash Flow Yield |
581.72% | 835.14% | (85.58%) | 730.96% | |
Revenue per Share |
8.22 | 7.88 | 6.84 | 6.38 | |
Operating CF per Share |
0.31 | (0.43) | 0.19 | (0.42) | |
Capex per Share |
2.20 | (0.10) | (0.07) | (0.06) | |
Free Cash Flow per Share |
2.51 | (0.53) | 0.12 | (0.48) | |
Cash per Share |
2.70 | 1.98 | 1.94 | 1.57 | |
Shareholders Equity per Share |
(10.39) | (10.63) | (9.36) | (8.56) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(10.39) | (10.63) | (9.36) | (8.56) | |
Free Cash Flow |
280.51 | (60.17) | 14.02 | (57.98) | |
Working Capital |
(2,975.58) | (2,809.35) | (2,201.32) | (2,025.69) | |
Capital Expenditures |
245.94 | (11.23) | (8.76) | (7.81) | |
Net Current Asset Value |
(4,355.36) | (4,164.69) | (3,527.08) | (3,342.71) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
(0.27) | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(0.83%) | (3.61%) | 8.82% | 7.40% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
497.28 | 480.75 | 412.56 | 418.32 | |
Average Payables |
224.87 | 187.93 | 200.83 | 181.53 | |
Average Assets |
4,362.19 | 4,117.55 | 3,759.06 | 3,612.99 | |
Average Common Equity |
(1,122.41) | (1,127.12) | (1,090.05) | (1,089.08) |
Columns are period end dates